Viewing Study NCT07142057


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2026-01-02 @ 1:16 PM
Study NCT ID: NCT07142057
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-26
First Post: 2025-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on Lung Cancer Patients
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Organization:

Study Overview

Official Title: An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on the Incidence of Pulmonary Infection and Survival in Lung Cancer Patients
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the impact of the 23-valent pneumonia vaccine on the incidence of pulmonary infection and survival in lung cancer patients, and to explore its preventive effect and safety in the lung cancer patients.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: